2-hexyloxybenzamide,
exalamide,
ortho-hexyloxybenzamide,
exalamide,
53370-90-4,
2-(Hexyloxy)benzamide,
Hyperan,
2-n-Hexyloxybenzamide,
o-Hexyloxybenzamide,
2-Hexyloxybenzamide,
Exalamida,
Exalamidum,
Benzamide, 2-(hexyloxy)-,
2-hexoxybenzamide,
o-(Hexyloxy)benzamide,
Exalamide [INN:JAN],
Exalamidum [INN-Latin],
Exalamida [INN-Spanish],
UNII-7JEC65JCG2,
H.P. 216,
EINECS 258-504-3,
BRN 2645003,
7JEC65JCG2,
BENZAMIDE, o-HEXYLOXY-,
CHEBI:31585,
CKSJXOVLXUMMFF-UHFFFAOYSA-N,
NCGC00095049-01,
DSSTox_CID_25899,
DSSTox_RID_81211,
DSSTox_GSID_45899,
CAS-53370-90-4,
ortho-hexyloxybenzamide,
Spectrum_001729,
Exalamide (JAN/INN),
AC1L1FNN,
Spectrum2_000869,
Spectrum5_001095,
KBioSS_002209,
DivK1c_000140,
SCHEMBL151112,
SPECTRUM1503403,
SPBio_000917,
BEN685,
CHEMBL1405973,
DTXSID9045899,
CTK8F9710,
HMS500G22,
KBio1_000140,
KBio2_002209,
KBio2_004777,
KBio2_007345,
NINDS_000140,
HMS1922C12,
Pharmakon1600-01503403,
HY-B1224,
ZINC1542919,
Tox21 111403,
Tox21_111403,
CCG-39743,
NSC758449,
AKOS016014129,
Tox21_111403_1,
CS-4872,
NSC-758449,
VA10874,
IDI1_000140,
NCGC00095049-02,
NCGC00095049-04,
AJ-26862,
AN-40751,
CJ-24332,
LS-26914,
SBI-0051822.P002,
FT-0630660,
D01585,
AB00052353_02,
370E904,
A829549,
SR-01000872750,
SR-01000872750-1,
BRD-K12609457-001-02-3,
pazopanib HCl,
C13H19NO2,
Hyperan, 2-(Hexyloxy)benzamide,
CID3316,
C13-H19-N-O2,
4-10-00-00177 (Beilstein Handbook Reference),
HBA,
5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide hydrochloride,
635702-64-6,